What Is Sermorelin?
Sermorelin is the first 29 amino acids of natural GHRH — the shortest fragment that retains full activity. It was an FDA-approved pediatric growth-hormone deficiency drug (Geref) until 2008, when it left the market for commercial reasons, and it has decades of clinical familiarity behind it.
That history made it the backbone of anti-aging and wellness-clinic GH programs: a nightly injection that nudges the pituitary's own output rather than replacing it, preserving natural feedback loops that direct HGH injections bypass.
What is Sermorelin studied for?
- •Growth hormone deficiency (former approved indication)
- •Age-related GH decline in wellness medicine
- •Sleep quality and recovery protocols
- •As a safer-profile alternative to direct HGH
Side effects & safety
Well characterized from clinical use: injection-site reactions, transient flushing, occasional headache. Its feedback-preserving mechanism is inherently self-limiting — one reason clinics favor it.
Legal & approval status
No longer an approved product but historically was; today prescribed via compounding in some jurisdictions and sold as a research chemical in others. WADA-banned in sport.
Typical dosing at a glance
Related peptides
Educational overview based on published research and commonly reported community protocols — not medical advice, and not an endorsement of any compound. Consult a licensed healthcare provider.